FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224999725> ?p ?o ?g. }

• W4224999725 abstract "Background The tumor microenvironment plays an important role in the occurrence and development of tumors. However, there are gaps in understanding the molecular and cellular interactions between tumor cells and the immune tumor microenvironment (TME). The aim of this study was to identify a novel gene that played an important role in the tumor microenvironment of lung adenocarcinoma (LUAD). Methods The gene expression profile and clinical data for LUAD were downloaded from TCGA database. First, we used the ESTIMATE algorithm to evaluate the immune and stromal scores accordingly. Also, we analyzed differentially expressed immune-related genes (IRGs) in the high and low immune/stromal score groups. Then, we used the protein–protein interaction network (PPI network) and a univariate Cox regression analysis to identify the hub gene. After that, we analyzed the relationship between CSF2RB expression and TNM stage/prognosis. Furthermore, gene set enrichment analysis (GSEA) was used to analyze the pathway regulated by CSF2RB and the Pearson correlation analysis method was used to analyze the correlation between the CSF2RB and immune cells. Finally, we used Western blot, real-time quantitative PCR (RT-qPCR), and immunohistochemistry (IHC) to validate CSF2RB expression in cancer and para-cancerous tissues. Results We identified that CSF2RB played an important role in the tumor microenvironment of LUAD. The expression of CSF2RB in tumor tissues was lower than that in normal tissues. Furthermore, the Kaplan–Meier plotter showed that a low CSF2RB expression was associated with poor survival and multivariate COX regression analysis revealed that the CSF2RB gene was an independent risk factor for prognosis, independent of whether patients received chemotherapy or radiotherapy. More importantly, a high expression of CSF2RB was related to early T, N, and clinical stages. GSEA analysis revealed that CSF2RB associated with diverse immune-related pathways, including T-cell receptor signaling pathway, Toll-like receptor signaling pathway, and B-cell receptor signaling pathway. CSF2RB expression levels were also positively related with the levels of infiltrating CD4+ T cells, macrophages, NK cells, and monocytes in LUAD. Finally, tumor tissues from LUAD patients were used for the assessment of CSF2RB expression. It was significantly lower in tumor sites than in adjacent normal tissues, which was consistent with data analysis. Conclusion CSF2RB effectively predicted the prognosis of patients with lung adenocarcinoma which could also be a potential target for cancer treatment and prevention. However, further studies are required to elucidate the function and regulatory mechanisms of CSF2RB and to develop some novel treatment strategies." @default.
• W4224999725 created "2022-04-29" @default.
• W4224999725 creator A5004028150 @default.
• W4224999725 creator A5008204710 @default.
• W4224999725 creator A5022822761 @default.
• W4224999725 creator A5050652226 @default.
• W4224999725 creator A5054265107 @default.
• W4224999725 creator A5071732943 @default.
• W4224999725 creator A5081342373 @default.
• W4224999725 creator A5088138942 @default.
• W4224999725 date "2022-04-28" @default.
• W4224999725 modified "2023-10-18" @default.
• W4224999725 title "CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma" @default.
• W4224999725 cites W1563300197 @default.
• W4224999725 cites W1792400068 @default.
• W4224999725 cites W1987355514 @default.
• W4224999725 cites W2016674121 @default.
• W4224999725 cites W2033278321 @default.
• W4224999725 cites W2049491375 @default.
• W4224999725 cites W2079201443 @default.
• W4224999725 cites W2097995306 @default.
• W4224999725 cites W2114533739 @default.
• W4224999725 cites W2126423964 @default.
• W4224999725 cites W2127686099 @default.
• W4224999725 cites W2128035403 @default.
• W4224999725 cites W2151927487 @default.
• W4224999725 cites W2170137783 @default.
• W4224999725 cites W2218779488 @default.
• W4224999725 cites W2272984102 @default.
• W4224999725 cites W2342631118 @default.
• W4224999725 cites W2411380396 @default.
• W4224999725 cites W2560367415 @default.
• W4224999725 cites W2609512644 @default.
• W4224999725 cites W2738462696 @default.
• W4224999725 cites W2746724778 @default.
• W4224999725 cites W2766425839 @default.
• W4224999725 cites W2806924223 @default.
• W4224999725 cites W2900046418 @default.
• W4224999725 cites W2905436605 @default.
• W4224999725 cites W2913728083 @default.
• W4224999725 cites W2923990740 @default.
• W4224999725 cites W2940004630 @default.
• W4224999725 cites W296951886 @default.
• W4224999725 cites W2982084340 @default.
• W4224999725 cites W2988973848 @default.
• W4224999725 cites W3012777143 @default.
• W4224999725 cites W3087832616 @default.
• W4224999725 cites W3095057922 @default.
• W4224999725 cites W3096364305 @default.
• W4224999725 cites W3134243975 @default.
• W4224999725 cites W3172911572 @default.
• W4224999725 cites W3214233691 @default.
• W4224999725 cites W4210738594 @default.
• W4224999725 doi "https://doi.org/10.3389/fonc.2022.822849" @default.
• W4224999725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35574409" @default.
• W4224999725 hasPublicationYear "2022" @default.
• W4224999725 type Work @default.
• W4224999725 citedByCount "6" @default.
• W4224999725 countsByYear W42249997252022 @default.
• W4224999725 countsByYear W42249997252023 @default.
• W4224999725 crossrefType "journal-article" @default.
• W4224999725 hasAuthorship W4224999725A5004028150 @default.
• W4224999725 hasAuthorship W4224999725A5008204710 @default.
• W4224999725 hasAuthorship W4224999725A5022822761 @default.
• W4224999725 hasAuthorship W4224999725A5050652226 @default.
• W4224999725 hasAuthorship W4224999725A5054265107 @default.
• W4224999725 hasAuthorship W4224999725A5071732943 @default.
• W4224999725 hasAuthorship W4224999725A5081342373 @default.
• W4224999725 hasAuthorship W4224999725A5088138942 @default.
• W4224999725 hasBestOaLocation W42249997251 @default.
• W4224999725 hasConcept C10515644 @default.
• W4224999725 hasConcept C121608353 @default.
• W4224999725 hasConcept C126322002 @default.
• W4224999725 hasConcept C143998085 @default.
• W4224999725 hasConcept C16930146 @default.
• W4224999725 hasConcept C203014093 @default.
• W4224999725 hasConcept C204232928 @default.
• W4224999725 hasConcept C2776107976 @default.
• W4224999725 hasConcept C2776256026 @default.
• W4224999725 hasConcept C2781182431 @default.
• W4224999725 hasConcept C2781197716 @default.
• W4224999725 hasConcept C502942594 @default.
• W4224999725 hasConcept C50382708 @default.
• W4224999725 hasConcept C54355233 @default.
• W4224999725 hasConcept C71924100 @default.
• W4224999725 hasConcept C86803240 @default.
• W4224999725 hasConcept C8891405 @default.
• W4224999725 hasConceptScore W4224999725C10515644 @default.
• W4224999725 hasConceptScore W4224999725C121608353 @default.
• W4224999725 hasConceptScore W4224999725C126322002 @default.
• W4224999725 hasConceptScore W4224999725C143998085 @default.
• W4224999725 hasConceptScore W4224999725C16930146 @default.
• W4224999725 hasConceptScore W4224999725C203014093 @default.
• W4224999725 hasConceptScore W4224999725C204232928 @default.
• W4224999725 hasConceptScore W4224999725C2776107976 @default.
• W4224999725 hasConceptScore W4224999725C2776256026 @default.
• W4224999725 hasConceptScore W4224999725C2781182431 @default.
• W4224999725 hasConceptScore W4224999725C2781197716 @default.
• W4224999725 hasConceptScore W4224999725C502942594 @default.
• W4224999725 hasConceptScore W4224999725C50382708 @default.

• next